Showing 1 to 2 of 2 results


OxiDx Secures Patent, Poised for Billion-Dollar Market Entry
Proteomics International's subsidiary OxiDx secured an Australian patent for its finger-prick oxidative muscle stress test, showing promise in detecting muscle damage in athletes and racehorses, with commercial rollout planned for mid-year in Australia and the US soon after.
OxiDx Secures Patent, Poised for Billion-Dollar Market Entry
Proteomics International's subsidiary OxiDx secured an Australian patent for its finger-prick oxidative muscle stress test, showing promise in detecting muscle damage in athletes and racehorses, with commercial rollout planned for mid-year in Australia and the US soon after.
Progress
48% Bias Score

PromarkerD: Predictive Diabetic Kidney Disease Test Launches in Australia
Proteomics International Laboratories launched its PromarkerD predictive test for diabetic kidney disease in Australia on World Kidney Day, initially in Western Australia and the Northern Territory, costing $245 per test and aiming for nationwide rollout and global expansion.

PromarkerD: Predictive Diabetic Kidney Disease Test Launches in Australia
Proteomics International Laboratories launched its PromarkerD predictive test for diabetic kidney disease in Australia on World Kidney Day, initially in Western Australia and the Northern Territory, costing $245 per test and aiming for nationwide rollout and global expansion.
Progress
48% Bias Score
Showing 1 to 2 of 2 results